Skip to main content
. 2022 Jun 11;14(12):2891. doi: 10.3390/cancers14122891

Figure 5.

Figure 5

Summary of the results of the mutational study of IDH1 using NGS in tumor and using BEAMing in plasma in patients with gliomas. BEAMing: Beads, Emulsion, Amplification and Magnetics, IDH1: isocitrate dehydrogenase type 1, PB: peripheral blood.